LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
Por um escritor misterioso
Descrição
Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als
World's First Inhalable COVID-19 Vaccine Approved in China - COVID-19 - mobile.
Daiichi Sankyo to supply omicron XBB.1.5-adapted COVID-19 vaccine in Japan
JCI - Article_in_issue
Anima Biotech - Company info. interviews, news
PharmaCompass – Grow Your Pharma Business Digitally
Daiichi Sankyo to establish Japan's first mRNA production facility
PharmaCompass – Grow Your Pharma Business Digitally
Anima Biotech - mRNA Lightning Platform
Knowledge Library -, Growth Advisory
China Accelerating Development of its First Homegrown mRNA Covid Vaccine - Bloomberg
BioSpectrum Asia Jan 2023 - Flip eBook Pages 1-50
AbbVie to Develop mRNA Modulators Using Anima Biotech Platform
Anima Biotech - mRNA Lightning Platform
Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
Anima Biotech - Company info. interviews, news
de
por adulto (o preço varia de acordo com o tamanho do grupo)
